Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Utidelone by BioStar Pharmaceuticals for Testicular Cancer: Likelihood of Approval
Utidelone is under clinical development by BioStar Pharmaceuticals and currently in Phase I for Testicular Cancer. According to GlobalData, Phase...
Utidelone by BioStar Pharmaceuticals for Fallopian Tube Cancer: Likelihood of Approval
Utidelone is under clinical development by BioStar Pharmaceuticals and currently in Phase I for Fallopian Tube Cancer. According to GlobalData,...
Utidelone by BioStar Pharmaceuticals for Gastric Cancer: Likelihood of Approval
Utidelone is under clinical development by BioStar Pharmaceuticals and currently in Phase II for Gastric Cancer. According to GlobalData, Phase...
Utidelone by BioStar Pharmaceuticals for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
Utidelone is under clinical development by BioStar Pharmaceuticals and currently in Phase III for Triple-Negative Breast Cancer (TNBC). According to...
Utidelone by BioStar Pharmaceuticals for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval
Utidelone is under clinical development by BioStar Pharmaceuticals and currently in Phase III for Human Epidermal Growth Factor Receptor 2...